This week’s episode of “WisBusiness: the Podcast” is with Doug Stafford, president and CEO of Pantherics Inc., a Milwaukee startup developing a pill-based alternative to treat asthma.

His company spun out of research from UW-Milwaukee, focused on ways to treat various inflammatory diseases of smooth muscles, including asthma, irritable bowel syndrome and other conditions.

“In asthma, there’s inflammation in the lung, and as a result of the inflammation, the muscle in the airways contract and that’s responsible for the difficulty breathing,” he said. “But it’s not just in the lung — there are other conditions in other organs in the body that have a similar disease process.” Read the full story here.